Skip to main content

New blood test for fatty liver disease

Advertisement

Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide and is estimated to affect around 30 per cent of the European population. Chronic fatty liver disease can lead to irreversible cirrhosis of the liver, for which the only treatment is a liver transplant. The early detection of patients with non-alcoholic fatty liver disease is therefore particularly important.

Non-alcoholic fatty liver disease, particularly advanced steatohepatitis (NASH, also known as fatty liver hepatitis), is associated with significant changes in the immune cells within the liver. Only recently has the increased accumulation of a subtype of phagocytes (macrophages), on the surface of which the TREM2 receptor is present in high quantities, been described in fatty liver. Nevertheless, the role of TREM2-positive macrophages in the context of fatty liver disease was previously unknown.

The research team at MedUni Vienna, led by Christoph Binder and Tim Hendrikx from the Clinical Institute of Laboratory Medicine, was able to demonstrate in an animal model that these specific phagocytes play a protective role in fibrosis – a precursor to liver cirrhosis. These cells are found in increased numbers in the affected areas of the liver during inflammatory processes associated with non-alcoholic fatty liver disease, where they accumulate particularly in areas of cell damage and fibrosis.

“By strengthening the protective function of TREM2-positive macrophages, new therapeutic approaches for the treatment of fatty liver hepatitis could be developed,” says Florentina Porsch, co-first author of the study. 

TREM2 is present in the body both as a membrane receptor on cells and in a soluble form (sTREM2), which can be detected in the blood. “TREM2 in its soluble form is an excellent biomarker for identifying and monitoring the status of advanced liver disease, which, if left untreated, can progress from fatty liver disease to incurable liver cirrhosis,” explains lead author Tim Hendrikx from the Clinical Institute of Laboratory Medicine at MedUni Vienna. 

Reference:
Medical University of Vienna
Hendrikx T et al., Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localise to fibrotic areas and limit NASH, J Hepatol. DOI: 10.1016/j.jhep.2022.06.004
https://www.sciencedirect.com/science/article/pii/S0168827822003592

#non-alcoholicfatty liver #NAFLD #NASH #TREM2 #liver cirrhosis #fibrosis #fatty liver steatohepatitis #medicine

  • Author

    Gernot Hofer

More on this topic
Hormones

Low testosterone in men: symptoms, causes and treatment

Fatigue, a reduced sex drive, and a lack of energy: these symptoms can have many causes. One possible explanation is a testosterone deficiency. However, it is not possible to determine whether testosterone levels are actually too low based solely on the symptoms or on a single blood test result.

Men's health
Men's health

PSA level: What does it mean, and when is it too high?




The PSA level is one of the best-known laboratory test results relating to the prostate. Many men come across it for the first time during a screening examination or when having symptoms investigated. An abnormal result often raises questions: Is this already a sign of prostate cancer? What levels are considered normal?

Prostate
Pollen allergy

The right diet for hay fever

Anyone suffering from hay fever should pay particular attention to their diet so as not to make the symptoms any worse.

Nutrition
Urology

Prostate health: What men need to know

The prostate is a gland in a man’s body that is only the size of a chestnut, but it plays a crucial role in well-being, urinary function and male sexuality. Benign enlargement and prostate cancer become more common in older age.

Prostate